4//SEC Filing
BDC CAPITAL INC. 4
Accession 0000930413-19-001627
CIK 0001408443other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 5:54 PM ET
Size
6.0 KB
Accession
0000930413-19-001627
Insider Transaction Report
Form 4
BDC CAPITAL INC.
10% Owner
Transactions
- Purchase
Common Shares
2019-05-08$15.00/sh+200,000$3,000,000→ 2,388,088 total
Footnotes (2)
- [F1]Consists of the purchase of shares reported hereunder and upon the closing of the Issuer's IPO of 1,094,011 shares held by BDC Capital, Inc., or BDC Capital, and 1,094,011 shares held by GO Capital, s.e.c., a fund for which BDC Capital is the general partner and investment manager. BDC Capital has the power to vote and the power to direct the disposition of all such shares held by itself and Go Capital, s.e.c. BDC Capital's investment in our company is managed by Amplitude Ventures Capital Management Inc., or Amplitude, of which Dion Madsen and Jean-Francois Pariseau serve as partners. Go Capital, s.e.c. is managed by Dominique Belanger, Managing Partner, Co-Investments at BDC Capital. BDC Capital retains the right to approve of certain investment, voting or divestiture decisions proposed by Amplitude, such decisions being approved, depending on their quantum and potential impact, by either senior management at BDC Capital or by BDC Capital's investment committee.
- [F2]The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by GO Capital, s.e.c., in which the Reporting Person has no pecuniary interest.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
IncorporatedCanada (Federal Level)
Related Parties
1- filerCIK 0001430885
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 5:54 PM ET
- Size
- 6.0 KB